The Clorox Company (NYSE:CLX) Shares Sold by CENTRAL TRUST Co

CENTRAL TRUST Co reduced its holdings in The Clorox Company (NYSE:CLX) by 6.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,873 shares of the company’s stock after selling 916 shares during the quarter. CENTRAL TRUST Co’s holdings in Clorox were worth $2,043,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the business. Redwood Park Advisors LLC acquired a new stake in Clorox during the fourth quarter worth about $26,000. Millstone Evans Group LLC acquired a new stake in Clorox during the fourth quarter worth about $31,000. Wood Tarver Financial Group LLC acquired a new stake in Clorox during the fourth quarter worth about $31,000. GKV Capital Management Co. Inc. acquired a new stake in Clorox during the fourth quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Clorox during the fourth quarter worth about $33,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of the company’s stock in a transaction dated Wednesday, May 7th. The shares were acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now owns 4,000 shares of the company’s stock, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.57% of the company’s stock.

Clorox Trading Down 1.5%

Shares of CLX opened at $122.12 on Wednesday. The company has a market capitalization of $15.05 billion, a P/E ratio of 21.92, a P/E/G ratio of 2.80 and a beta of 0.54. The Clorox Company has a one year low of $121.98 and a one year high of $171.37. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The stock has a 50-day moving average price of $134.30 and a 200 day moving average price of $147.74.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same period in the prior year, the company posted $1.71 EPS. The company’s revenue for the quarter was down 8.0% on a year-over-year basis. Sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CLX has been the subject of several research analyst reports. Citigroup dropped their price target on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. Barclays dropped their price target on Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a research note on Wednesday, May 7th. Evercore ISI set a $140.00 price target on Clorox and gave the stock an “underperform” rating in a research note on Tuesday, May 6th. UBS Group lowered their target price on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research note on Thursday, April 17th. Finally, JPMorgan Chase & Co. lowered their target price on Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a research note on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, Clorox has an average rating of “Hold” and an average price target of $151.23.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.